Personalized Care : In order to meet the needs of each patient, each treatment is customized to meet those needs
The genuine unknown is long-term effects in humans
Mitochondrial Decline Your mitochondria power every cell in your body
Tanya Altmann

Members of the INNODIA and INNODIA HARVEST consortia Mathieu C, Gillard P, Casteels K, Overbergh L (KU Leuven, Belgium), Dunger D, Wallace C, Evans M, Thankamony A, Hendriks E, Bruggraber S, Qureshi A, Marcovecchio L, Paediatrics laboratory staff (University of Cambridge, UK), Peakman M, Tree T (Kings College London, UK), Morgan N, Richardson S (University of Exeter, UK), Todd J, Wicker L (University of Oxford, UK), Mander A, Dayan C, Alhadj Ali M (Cardiff University, UK), Pieber T (Medical University of Graz, Austria), Eizirik D, Cnop M (Universite Libre de Bruxelles, Belgium), Brunak S (University of Copenhagen, Denmark), Pociot F, Johannesen J, Rossing P, Legido Quigley C (Herlev University Hospital, Region Hovedstaden, Denmark), Mallone R, Scharfmann R, Boitard C (Cochin Institute Paris, France), Knip M, Otonkoski T (University of Helsinki, Finland), Veijola R (University of Oulu, Finland), Lahesmaa R, Oresic M, Toppari J (University of Turku, Finland), Danne T (Children's and Youth Hospital Hannover, Germany), Ziegler AG, Achenbach P, Rodriguez-Calvo T (Helmholtz Zentrum Muenchen, Germany), Solimena M, Bonifacio E, Speier S (TU Dresden, Germany), Holl R (University of Ulm, Germany), Dotta F (University of Siena, Italy), Chiarelli F (University of Chieti, Italy), Marchetti P (University of Pisa, Italy), Bosi E (University Vita-Salute San Raffaele, Italy), Cianfarani S, Ciampalini P (Bambino Ges Children's Hospital, Italy), de Beaufort C (Centre Hospitalier de Luxembourg, Luxemburg), Dahl-Jrgensen K, Skrivarhaug T, Joner G, Krogvold L (Oslo University Hospital, Norway), Jarosz-Chobot P (Medical University of Silesia, Poland), Battelino T (University of Ljubljana, Slovenia), Thorens B (University of Lausanne, Switzerland), Gotthardt M (Radboud University Medical Center, the Netherlands), Roep B, Nikolic T, Zaldumbide A (Leiden University Medical Center, the Netherlands), Lernmark A, Lundgren M (Lund University, Sweden), Costecalde G (Univercell-Biosolutions, France), Strube T, Schulte A, Nitsche A, (Sanofi, Germany), Peakman M, Vela J (Sanofi, United States), von Herrath M, Wesley J, (Novo Nordisk, Denmark), Napolitano-Rosen A (GlaxoSmithKline, UK), Thomas M, Schloot N (Eli Lilly, UK), Goldfine A, Waldron-Lynch F, Kompa J, Vedala A, Hartmann N, Nicolas G (Novartis Pharma AG, Switzerland), van Rampelbergh J, Bovy N (Imcyse SA, Belgium), Dutta S, Soderberg J, Ahmed S, Martin F, Latres E (JDRF, USA), Agiostratidou G, Koralova A (The Leona M

NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer